4
Changes in Ownership
ORASURE TECHNOLOGIES INC Filed Acc 0001209784-18-000012
EVP & BU Lead - Molecular sold 20,000 shares at an average $17.97 ($359,460)
- EVP & BU Lead - Molecular acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SMITH BRIAN · EVP & BU Lead - Molecular
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 1 in the form | +10,000 | $5.96 | $59,590 | 28,075 | D |
| 2018-02-15 | Sale : show line 2 in the form | −10,000 | $17.95 | $179,450 | 18,075 | D |
| 2018-02-16 | Exercise or conversion : show line 3 in the form | +10,000 | $5.96 | $59,590 | 28,075 | D |
| 2018-02-16 | Sale : show line 4 in the form | −10,000 | $18.00 | $180,010 | 18,075 | D |
| Open-market sales · 20,000 sh · avg $17.97 · $359,460 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-02-15 | Exercise or conversion : show line 5 in the form Nonqualified stock options | −10,000 | $5.96 | 2023-12-20 | 10,000 | 10,000 | D |
| 2018-02-16 | Exercise or conversion : show line 6 in the form Nonqualified stock options | −10,000 | $5.96 | 2023-12-20 | 10,000 | 0 | D |
Loading xslF345X03/edgar.xml…